Suppr超能文献

[迟发性压力性荨麻疹:对西替利嗪的治疗反应]

[Delayed pressure urticaria: therapeutic response to cetirizine].

作者信息

Tadmor B, Rubinow A, Shalit M

机构信息

Allergy and Clinical Immunology Unit, Hebrew University-Hadassah Medical School, Jerusalem.

出版信息

Harefuah. 1993 Jun 1;124(11):683-5, 739.

PMID:8344626
Abstract

We describe a 39-year-old man who suffered from delayed pressure urticaria for 2 years. His severe symptoms did not respond to antihistamine (H1 and H2) treatment and corticosteroid therapy was given despite severe side-effects. A new, nonsedating antihistamine drug, cetirizine, relieved most of his symptoms, enabled him to be weaned from corticosteroid therapy, and restored his former quality of life.

摘要

我们描述了一名39岁的男性,他患有迟发性压力性荨麻疹达2年之久。他的严重症状对抗组胺药(H1和H2)治疗无反应,尽管有严重的副作用,仍给予了皮质类固醇治疗。一种新型的非镇静性抗组胺药物西替利嗪缓解了他的大部分症状,使他能够逐渐停用皮质类固醇治疗,并恢复了他以前的生活质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验